Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Linde PLC Director's Dealing 2023

Feb 15, 2023

9953_dirs_2023-02-15_9f3e1323-9c6c-41c1-a3f1-99610cfebfd6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LINDE PLC (LIN)
CIK: 0001707925
Period of Report: 2023-02-13

Reporting Person: Lamba Sanjiv (Director, Chief Executive Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-13 Deferred Stock Units $143.57 A 143.57 Acquired Ordinary Shares (143.57) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 47084 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Ordinary Shares (6335) 6335 Direct
Restricted Stock Units $ Ordinary Shares (3895) 3895 Direct
Restricted Stock Units $ Ordinary Shares (3090) 3090 Direct
Stock Options (right to buy) $270.99 2032-03-07 Ordinary Shares (54920) 54920 Direct
Stock Option (right to buy) $253.68 2031-03-08 Ordinary Shares (40995) 40995 Direct
Stock Option (right to buy) $173.13 2030-03-09 Ordinary Shares (37565) 37565 Direct
Stock Option (right to buy) $176.63 2029-03-20 Ordinary Shares (40470) 40470 Direct

Footnotes

F1: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

F2: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.

F4: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

F5: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

F7: Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.

F8: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F9: Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.